Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Diamantopoulos, P.T."'
Autor:
Vlachopoulou, D., Kontandreopoulou, C.-N., Diamantopoulos, P.T., Syriopoulou, S., Stafylidis, C., Katsiampoura, P., Galanopoulos, A., Dimou, M., Panayiotidis, P., Viniou, N.-A.
Publikováno v:
In Leukemia Research Reports 2024 21 Supplement
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charakopoulos, E. Diamantopoulos, P.T. Zervakis, K. Giannakopoulou, N. Psichogiou, M. Viniou, N.-A.
Introduction: Aeromonads are gram-negative opportunistic bacteria, mainly found in aquatic environments. Hematologic patients are particularly at risk of Aeromonas soft tissue infections and septicemia, especially during chemotherapy-induced neutrope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::952a620bd9c3bf1d980d4788187dfce1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220647
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220647
5-azacytidine (5-AZA) is considered the standard of care for patients with high-risk myelodysplastic syndromes (MDS) and patients with acute myeloid leukemia (AML) not candidate for intensive chemotherapy. However, even after an initial favorable res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1206d9f5cc654034239adfb0095cbb0f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119883
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119883
The introduction of hypomethylating agents (HMAs) 5-azacytidine and decitabine has altered the prognosis of patients with myelodysplastic syndrome (MDS). Over the past few years, the International Prognostic Scoring System (IPSS) and the revised IPSS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::db77222eb1ae807e55d75b9a2bb4f490
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119857
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119857
Background: Polycythemia vera (PV) is characterized by red cell mass expansion in the peripheral blood and can be complicated with thrombosis, bleeding, evolution to acute myeloid leukemia (AML) or a fibrotic phase. Paroxysmal nocturnal hemoglobinuri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e84e60a3feab38cea9d9890c0e0f7b77
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101719
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101719
Background: Hypomethylating agents have altered the prognosis of myelodysplastic syndrome (MDS) so that long-term survival is now a feasible treatment goal. Patients and Methods: We analyzed data from patients with MDS treated with 5-azacytidine reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9769b866e314facc62de343ca9b5b9f0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078653
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078653
New primary melanomas (NPMs) in the era of combination treatments for melanoma constitute a challenge for physicians, especially due to the increased incidence of NPMs in patients treated with BRAF inhibitors. We present the unique case of a patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::86a6ae250b4322a5adc4f19c8db4a223
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3079036
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3079036
After the approval of immune checkpoint inhibitors for the treatment of many solid tumors, a new class of adverse events was recognized through the augmented activation of T cells, known as immune-related toxicities (immune-related adverse events). E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1e8ced17f3212f06ad46d329e2c00298
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003307
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003307